Site intended for UK audience


Atofab® contains the active substance atomoxetine and is used to treat attention deficit hyperactivity disorder (ADHD).

It is given to adults, adolescents and children aged 6 years and older.

Atomoxetine is used as part of a comprehensive treatment programme for this disorder, but also requires non-drug interventions such as counselling and behavioural therapy.

It is not intended for ADHD treatment in children under 6 years of age, as the efficacy and safety of the medicine in this patient group are not known.

In adults, ADHD treatment with Atofab® is indicated if the signs of the disease are very distressing and affect the patient’s professional or social life, and if the ADHD signs were already present in childhood.

Active substance: Atomoxetine

Strength Pack size
10 mg 10, 30
18 mg 10, 30
25 mg 10, 30
40 mg 10, 30
60 mg 10, 30
80 mg 30
100 mg 30

Physicians / Pharmacists Login

We ask for your understanding that due to the Austrian Medicines Act, certain further information is only accessible to medical professionals.

Login Physicians / Pharmacists Login